Tumor-derived TGM2 drives macrophage-mediated angiogenesis via the PKM2/STAT1/CCL2 axis in gastric cancer

Transglutaminase 2 (TGM2) has been implicated in the regulation of angiogenesis, but the underlying mechanisms remain largely elusive. This study aimed to systematically elucidate the functional role and molecular mechanisms through which tumor-derived TGM2 modulates angiogenesis in gastric cancer. Bioinformatics analysis and a combination of in vivo and in vitro assays were utilized to dissect the role and mechanisms of TGM2 in angiogenesis (e.g., xenograft tumor models, single-cell RNA sequencing, flow cytometry, mass spectrometry, Western blotting, and chromatin immunoprecipitation). Additionally, tumor-bearing mice were treated with Calcimycin to evaluate whether targeting TGM2 could regulate angiogenesis. CD31 was highly expressed in gastric cancer tissues and exhibited a significant positive correlation with TGM2 expression. In vivo, TGM2 promoted angiogenesis in murine subcutaneous tumors, a process accompanied by increased infiltration of VEGFA+ M2d macrophages. Mechanistic studies revealed that TGM2 enhanced the transcription and secretion of CCL2, thereby inducing macrophage polarization towards the VEGFA+ M2d subset. At the molecular level, GTP-bound TGM2 functioned as a protein kinase, promoting the phosphorylation and dimerization of pyruvate kinase M2 (PKM2). Dimerized PKM2 further mediated the phosphorylation and nuclear translocation of STAT1, ultimately driving CCL2 transcription. Targeting GTP-bound TGM2 with Calcimycin reversed the aforementioned pathway. Notably, tumor-bearing mice with high TGM2 expression showed greater sensitivity to Calcimycin treatment, as evidenced by reduced angiogenesis and inhibited M2d macrophage differentiation. This study uncovers a novel TGM2-PKM2/STAT1-CCL2 axis regulating M2d macrophage differentiation and angiogenesis in GC, establishing TGM2 as a promising therapeutic target and predictive biomarker.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2026-11-21
DOI
https://doi.org/10.1038/s41419-026-09459-6
Primary Topic
Angiogenesis and VEGF in Cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Tumor-derived TGM2 drives macrophage-mediated angiogenesis via the PKM2/STAT1/CCL2 axis in gastric cancer

Yikai Shen, Zetian Chen, Lu Zhang, Jianghao Xu et al.
Cell Death and Disease
Angiogenesis and VEGF in Cancer
article

Tumor-derived TGM2 drives macrophage-mediated angiogenesis via the PKM2/STAT1/CCL2 axis in gastric cancer

Yikai Shen, Zetian Chen, Lu Zhang, Jianghao Xu, Hongxin Huang, Qingya Li
article en

Abstract

Transglutaminase 2 (TGM2) has been implicated in the regulation of angiogenesis, but the underlying mechanisms remain largely elusive. This study aimed to systematically elucidate the functional role and molecular mechanisms through which tumor-derived TGM2 modulates angiogenesis in gastric cancer. Bioinformatics analysis and a combination of in vivo and in vitro assays were utilized to dissect the role and mechanisms of TGM2 in angiogenesis (e.g., xenograft tumor models, single-cell RNA sequencing, flow cytometry, mass spectrometry, Western blotting, and chromatin immunoprecipitation). Additionally, tumor-bearing mice were treated with Calcimycin to evaluate whether targeting TGM2 could regulate angiogenesis. CD31 was highly expressed in gastric cancer tissues and exhibited a significant positive correlation with TGM2 expression. In vivo, TGM2 promoted angiogenesis in murine subcutaneous tumors, a process accompanied by increased infiltration of VEGFA+ M2d macrophages. Mechanistic studies revealed that TGM2 enhanced the transcription and secretion of CCL2, thereby inducing macrophage polarization towards the VEGFA+ M2d subset. At the molecular level, GTP-bound TGM2 functioned as a protein kinase, promoting the phosphorylation and dimerization of pyruvate kinase M2 (PKM2). Dimerized PKM2 further mediated the phosphorylation and nuclear translocation of STAT1, ultimately driving CCL2 transcription. Targeting GTP-bound TGM2 with Calcimycin reversed the aforementioned pathway. Notably, tumor-bearing mice with high TGM2 expression showed greater sensitivity to Calcimycin treatment, as evidenced by reduced angiogenesis and inhibited M2d macrophage differentiation. This study uncovers a novel TGM2-PKM2/STAT1-CCL2 axis regulating M2d macrophage differentiation and angiogenesis in GC, establishing TGM2 as a promising therapeutic target and predictive biomarker.

Cell Death and Disease
Jiangsu Province Hospital (CN), Nanjing Medical University (CN)
Angiogenesis and VEGF in Cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon